BINVBrandes International ETF
Seeks long term capital appreciation.
By Brandes · Launched 2023
Annual Cost
0.70%
#3,681 of 5,861 · average
Fund Size
$490M
#1,606 of 5,861 · large
Return (1Y)Goal
+27.4%
Track Record
2 years
#3,143 of 5,861 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,846+28.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 24.2% of fund✓ well diversified
Sanofi SA
3.2%
Petroleo Brasileiro SA
2.8%
Takeda Pharmaceutical Co Ltd.
2.6%
WAL-MART DE MEXICO SAB DE CV (WAL-MART DE MEXICO SA DE CV)
2.4%
Wilmar International Ltd.
2.4%
Astellas Pharma Inc.
2.3%
SAP SE
2.3%
ALIBABA GROUP HOLDING LTD
2.2%
Carrefour S.A.
2.1%
Heineken Holding N.V.
2.0%
Asset allocation
Stocks
99.2%
Cash
0.8%
By sector
Consumer Defensive
24.2%
Healthcare
17.2%
Consumer Cyclical
14.6%
Industrials
10.6%
Technology
8.3%
Financial Services
8.0%
Communication
6.4%
Basic Materials
5.0%
Other
5.8%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
13.8%Moderate
Year-on-year price swings
Max drawdown
-14.9%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in equity securities of foreign companies, focusing on those with market capitalizations greater than $5 billion. The Advisor employs value investing principles to select securities, aiming for long-term capital appreciation by purchasing undervalued stocks and assessing intrinsic value.
- Inception date
- October 3, 2023
- Fund family
- Brandes
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at BINV. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04